Zetta Genomics Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Zetta Genomics Limited - overview
Established
2018
Location
Cambridge, -, UK
Primary Industry
Biotechnology
About
Established in 2018 and based in Cambridge, UK, Zetta Genomics Limited operates as a biotechnology company that provides data management solutions on genomic data technology and precision medicine. The company is a spinout from two genomic data pioneers, the University of Cambridge and Genomics England, and was founded by its CTO, Ignacio Medina. In April 2023, Zetta Genomics Limited raised GBP 1. 9 million in seed funding led by Nina Capital, Apex Ventures, and Cambridge Enterprise.
As of 2023, the company’s CEO is Mark Bailey. Zetta Genomics offers XetaBase, a cloud-based genomic data management platform that is built on the open-source CB (CellBase) platform and helps researchers and clinicians in the genomic, biomedical, and pharmaceutical industries analyze and manage genomic data. The firm’s data analytics platform enables users to aggregate and integrate more than 10TB of reference data from over 20 reference sources and store, retrieve, and annotate genotype data. The firm also offers web services, APIs for programming languages like R and Python, and an IVA web application dashboard tool for visualization.
The company plans to use the funds raised in April 2023 to scale its genomic data management platform.
Current Investors
Parkwalk Advisors, Cambridge Enterprise, Apex Ventures
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Molecular Science, Genetics & Gene Therapy, Healthcare IT, Analytics & Performance Software
Website
www.zettagenomics.com
Verticals
Cloud Computing, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.